Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Orca Bio makes a splash with FDA approval for cell therapy Tregzi. Could an IPO come next?
Orca Bio has jumped into the commercial market with an FDA approval for Tregzi, a first-of-its-kind engineered cell therapy for blood cancer patients requiring transplants. | Orca Bio has jumped into the commercial market with an FDA approval for Tregzi, a first-of-its-kind allogeneic regulatory T cell-based therapy for blood cancer patients requiring transplants.
1,081 words~5 min read
